This IPO Stock Does Even Better Than Nvidia In Six Months Flat
In This Article:
IPO stock PACS is near a buy point after doubling in price in six months flat. The post-acute health care provider has outperformed Nvidia during that time.
IPO stock PACS is near a buy point after doubling in price in six months flat. The post-acute health care provider has outperformed Nvidia during that time.
Try again.